Treatment of a severe vascular disease using a bespoke CRISPR-Cas9 base editor in mice. - Alves CRR; Das S; Krishnan V; Ha LL; Fox LR; Stutzman HE; Shamber CE; Kalailingam P; McCarthy S; Lino Cardenas CL; Fong CE; Imai T; et al. (Nature biomedical engineering, 2026)